All treatments
Treatment
5 mg/ml – Concentrato per soluzione per infusione clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic confirmatory (Phase III)
A randomized phase III trial of short-course versus long-course pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III pancreatic ductal adenocarcinoma (PDAC)
This study looks at different ways to give chemotherapy before surgery for pancreatic cancer. We want to see if a shorter or longer course of treatment works better in helping people live longer and preventing the cancer from growing.
For: pancreatic ductal adenocarcinomaItaly - Ongoing, recruitingTherapeutic exploratory (Phase II)
Electrochemotherapy as a first line treatment in recurrent squamous cell carcinoma of the oral cavity and oropharynx: a randomized controlled trial (ECT-HN)
This study looks at a new way to treat certain mouth and throat cancers that have come back. It compares electrochemotherapy with a drug called bleomycin against a standard treatment mix. The goal is to see if the new method shrinks the cancer more effectively.
For: CARCINOMA OF THE ORAL CAVITY AND OROPHARYNXItaly